{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:16:35Z","timestamp":1790421395124,"version":"4.1.0"},"reference-count":37,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Multilineage-differentiating stress-enduring (Muse) cells are pluripotent stem cells, which can be harvested from the bone marrow. After transplantation, Muse cells can migrate to an injured site of the body and exert repair effects. However, it remains unknown whether Muse cell transplantation can be an effective treatment in spinal cord injury (SCI).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>The authors used a rat model of thoracic spinal cord contusion injury. For Muse cell transplantation, the clinical product CL2020 containing 300,000 Muse cells was administered intravenously 1 day after midthoracic SCI. Animals were divided into CL2020 (n = 11) and vehicle-treated (n = 15) groups. Behavioral and histological evaluations were conducted over a period of 8 weeks to see whether intravenous CL2020 administration provided therapeutic effects for SCI. The effects of human-selective diphtheria toxin on reversion of the therapeutic effects of CL2020 were also investigated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Hindlimb motor function significantly improved after CL2020 transplantations. Importantly, the effects were reverted by the human-selective diphtheria toxin. In immunohistochemical analyses, the cystic cavity formed after the injury was smaller in the CL2020 group. Furthermore, higher numbers of descending 5-hydroxytryptamine (5-HT) fibers were preserved distal to the injury site after CL2020 administration. Eight weeks after the injury, Muse cells in CL2020 were confirmed to differentiate most predominantly into neuronal cells in the injured spinal cord.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>Following SCI, Muse cells in CL2020 can reach the injured spinal cord after intravenous administration and differentiate into neuronal cells. Muse cells in CL2020 facilitated nerve fiber preservation and exerted therapeutic potential for severe SCI.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2020.7.spine20293","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T07:19:23Z","timestamp":1609485563000},"page":"648-655","source":"Crossref","is-referenced-by-count":30,"title":["Association of intravenous administration of human Muse cells with deficit amelioration in a rat model of spinal cord injury"],"prefix":"10.3171","volume":"34","author":[{"given":"Takumi","family":"Kajitani","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine;"},{"name":"Department of Neurosurgery, Sendai Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Iwabuchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sendai Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatsugu","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyasu","family":"Niizuma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine;"},{"name":"Department of Neurosurgical Engineering and Translational Neuroscience, Tohoku University Graduate School of Biomedical Engineering; and"},{"name":"Department of Neurosurgical Engineering and Translational Neuroscience, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"Tominaga","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"21","key":"b1","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1089\/neu.2015.3963","article-title":"Methylprednisolone for the treatment of patients with acute spinal cord injuries: a propensity score-matched cohort study from a Canadian multi-center spinal cord injury registry","volume":"32","author":"Evaniew \nN","year":"2015","unstructured":"Evaniew \nN\n, \n\nNoonan \nVK\n, \n\nFallah \nN\n, \n\n \nMethylprednisolone for the treatment of patients with acute spinal cord injuries: a propensity score-matched cohort study from a Canadian multi-center spinal cord injury registry. \nJ Neurotrauma. \n2015;\n32(\n21):\n1674\u2013\n1683.\n2606570610.1089\/neu.2015.3963"},{"issue":"4","key":"b2","series-title":"Paraplegia","first-page":"183","article-title":"A nationwide epidemiological survey of spinal cord injuries in Japan from January 1990 to December 1992","volume":"33","author":"Shingu \nH","year":"1995","unstructured":"Shingu \nH\n, \n\nOhama \nM\n, \n\nIkata \nT\n, \n\n \nA nationwide epidemiological survey of spinal cord injuries in Japan from January 1990 to December 1992. \nParaplegia. \n1995;\n33(\n4):\n183\u2013\n188.\n7609973"},{"issue":"2","key":"b3","series-title":"Spinal Cord","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sc.2012.158","article-title":"The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate","volume":"52","author":"Lee \nBB","year":"2014","unstructured":"Lee \nBB\n, \n\nCripps \nRA\n, \n\nFitzharris \nM\n, \n\nWing \nPC\n\n. \nThe global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate. \nSpinal Cord. \n2014;\n52(\n2):\n110\u2013\n116.\n10.1038\/sc.2012.15823439068"},{"issue":"13","key":"b4","series-title":"Neuroreport","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1097\/00001756-200009110-00035","article-title":"Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation","volume":"11","author":"Chopp \nM","year":"2000","unstructured":"Chopp \nM\n, \n\nZhang \nXH\n, \n\nLi \nY\n, \n\n \nSpinal cord injury in rat: treatment with bone marrow stromal cell transplantation. \nNeuroreport. \n2000;\n11(\n13):\n3001\u2013\n3005.\n10.1097\/00001756-200009110-0003511006983"},{"issue":"1","key":"b5","series-title":"Neuropathology","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1440-1789.2010.01130.x","article-title":"Transplantation of human bone marrow stromal cell-derived Schwann cells reduces cystic cavity and promotes functional recovery after contusion injury of adult rat spinal cord","volume":"31","author":"Kamada \nT","year":"2011","unstructured":"Kamada \nT\n, \n\nKoda \nM\n, \n\nDezawa \nM\n, \n\n \nTransplantation of human bone marrow stromal cell-derived Schwann cells reduces cystic cavity and promotes functional recovery after contusion injury of adult rat spinal cord. \nNeuropathology. \n2011;\n31(\n1):\n48\u2013\n58.\n2057303210.1111\/j.1440-1789.2010.01130.x"},{"issue":"3","key":"b6","series-title":"J Neurosci Res","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/jnr.10587","article-title":"Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord","volume":"72","author":"Wu \nS","year":"2003","unstructured":"Wu \nS\n, \n\nSuzuki \nY\n, \n\nEjiri \nY\n, \n\n \nBone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. \nJ Neurosci Res. \n2003;\n72(\n3):\n343\u2013\n351.\n1269290110.1002\/jnr.10587"},{"issue":"5","key":"b7","series-title":"Int J Mol Sci","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3390\/ijms20051054","article-title":"Application of hepatocyte growth factor for acute spinal cord injury: the road from basic studies to human treatment","volume":"20","author":"Kitamura \nK","year":"2019","unstructured":"Kitamura \nK\n, \n\nNagoshi \nN\n, \n\nTsuji \nO\n, \n\n \nApplication of hepatocyte growth factor for acute spinal cord injury: the road from basic studies to human treatment. \nInt J Mol Sci. \n2019;\n20(\n5):\n1054.\n10.3390\/ijms2005105430823442"},{"issue":"12","key":"b8","series-title":"Eur Spine J","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1007\/s00586-012-2213-3","article-title":"Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I\/IIa clinical trial","volume":"21","author":"Takahashi \nH","year":"2012","unstructured":"Takahashi \nH\n, \n\nYamazaki \nM\n, \n\nOkawa \nA\n, \n\n \nNeuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I\/IIa clinical trial. \nEur Spine J. \n2012;\n21(\n12):\n2580\u2013\n2587.\n10.1007\/s00586-012-2213-322391867"},{"issue":"13","key":"b9","series-title":"Regen Ther","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.reth.2019.05.006","article-title":"Cell therapy for spinal cord injury using induced pluripotent stem cells","volume":"11","author":"Nagoshi \nN","year":"2019","unstructured":"Nagoshi \nN\n, \n\nTsuji \nO\n, \n\nNakamura \nM\n, \n\nOkano \nH\n\n. \nCell therapy for spinal cord injury using induced pluripotent stem cells. \nRegen Ther. \n2019;\n11(\n13):\n75\u2013\n80.\n3124545110.1016\/j.reth.2019.05.006"},{"issue":"4","key":"b10","series-title":"Expert Opin Ther Targets","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1517\/14728222.2011.553605","article-title":"Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages","volume":"15","author":"Gensel \nJC","year":"2011","unstructured":"Gensel \nJC\n, \n\nDonnelly \nDJ\n, \n\nPopovich \nPG\n\n. \nSpinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. \nExpert Opin Ther Targets. \n2011;\n15(\n4):\n505\u2013\n518.\n2128125610.1517\/14728222.2011.553605"},{"issue":"1","key":"b11","series-title":"Clin Orthop Surg","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4055\/cios.2017.9.1.1","article-title":"Spinal cord injury and related clinical trials","volume":"9","author":"Kim \nYH","year":"2017","unstructured":"Kim \nYH\n, \n\nHa \nKY\n, \n\nKim \nSI\n\n. \nSpinal cord injury and related clinical trials. \nClin Orthop Surg. \n2017;\n9(\n1):\n1\u2013\n9.\n2826142110.4055\/cios.2017.9.1.1"},{"issue":"19","key":"b12","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"8639","DOI":"10.1073\/pnas.0911647107","article-title":"Unique multipotent cells in adult human mesenchymal cell populations","volume":"107","author":"Kuroda \nY","year":"2010","unstructured":"Kuroda \nY\n, \n\nKitada \nM\n, \n\nWakao \nS\n, \n\n \nUnique multipotent cells in adult human mesenchymal cell populations. \nProc Natl Acad Sci U S A. \n2010;\n107(\n19):\n8639\u2013\n8643.\n10.1073\/pnas.091164710720421459"},{"issue":"24","key":"b13","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"9875","DOI":"10.1073\/pnas.1100816108","article-title":"Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts","volume":"108","author":"Wakao \nS","year":"2011","unstructured":"Wakao \nS\n, \n\nKitada \nM\n, \n\nKuroda \nY\n, \n\n \nMultilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. \nProc Natl Acad Sci U S A. \n2011;\n108(\n24):\n9875\u2013\n9880.\n2162857410.1073\/pnas.1100816108"},{"issue":"7","key":"b14","series-title":"Nat Protoc","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nprot.2013.076","article-title":"Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells","volume":"8","author":"Kuroda \nY","year":"2013","unstructured":"Kuroda \nY\n, \n\nWakao \nS\n, \n\nKitada \nM\n, \n\n \nIsolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. \nNat Protoc. \n2013;\n8(\n7):\n1391\u2013\n1415.\n2378789610.1038\/nprot.2013.076"},{"issue":"1-2","key":"b15","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2004.02.072","article-title":"Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats","volume":"1010","author":"Borlongan \nCV","year":"2004","unstructured":"Borlongan \nCV\n, \n\nLind \nJG\n, \n\nDillon-Carter \nO\n, \n\n \nBone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. \nBrain Res. \n2004;\n1010(\n1-2):\n108\u2013\n116.\n10.1016\/j.brainres.2004.02.07215126123"},{"issue":"2","key":"b16","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/STROKEAHA.119.026589","article-title":"Intravenously transplanted human multilineage-differentiating stress-enduring cells afford brain repair in a mouse lacunar stroke model","volume":"51","author":"Abe \nT","year":"2020","unstructured":"Abe \nT\n, \n\nAburakawa \nD\n, \n\nNiizuma \nK\n, \n\n \nIntravenously transplanted human multilineage-differentiating stress-enduring cells afford brain repair in a mouse lacunar stroke model. \nStroke. \n2020;\n51(\n2):\n601\u2013\n611.\n10.1161\/STROKEAHA.119.026589"},{"issue":"8","key":"b17","series-title":"Circ Res","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/CIRCRESAHA.117.311648","article-title":"S1P-S1PR2 axis mediates homing of Muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction","volume":"122","author":"Yamada \nY","year":"2018","unstructured":"Yamada \nY\n, \n\nWakao \nS\n, \n\nKushida \nY\n, \n\n \nS1P-S1PR2 axis mediates homing of Muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction. \nCirc Res. \n2018;\n122(\n8):\n1069\u2013\n1083.\n2947598310.1161\/CIRCRESAHA.117.311648"},{"issue":"2","key":"b18","series-title":"Am J Transplant","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/ajt.13537","article-title":"A distinct subpopulation of bone marrow mesenchymal stem cells, Muse cells, directly commit to the replacement of liver components","volume":"16","author":"Katagiri \nH","year":"2016","unstructured":"Katagiri \nH\n, \n\nKushida \nY\n, \n\nNojima \nM\n, \n\n \nA distinct subpopulation of bone marrow mesenchymal stem cells, Muse cells, directly commit to the replacement of liver components. \nAm J Transplant. \n2016;\n16(\n2):\n468\u2013\n483.\n10.1111\/ajt.13537"},{"issue":"5","key":"b19","series-title":"Cell Transplant","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3727\/096368916X693662","article-title":"Muse cells, nontumorigenic pluripotent-like stem cells, have liver regeneration capacity through specific homing and cell replacement in a mouse model of liver fibrosis","volume":"26","author":"Iseki \nM","year":"2017","unstructured":"Iseki \nM\n, \n\nKushida \nY\n, \n\nWakao \nS\n, \n\n \nMuse cells, nontumorigenic pluripotent-like stem cells, have liver regeneration capacity through specific homing and cell replacement in a mouse model of liver fibrosis. \nCell Transplant. \n2017;\n26(\n5):\n821\u2013\n840.\n10.3727\/096368916X693662"},{"issue":"1","key":"b20","series-title":"Stem Cells","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/stem.2206","article-title":"Transplantation of unique subpopulation of fibroblasts, Muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation","volume":"34","author":"Uchida \nH","year":"2016","unstructured":"Uchida \nH\n, \n\nMorita \nT\n, \n\nNiizuma \nK\n, \n\n \nTransplantation of unique subpopulation of fibroblasts, Muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. \nStem Cells. \n2016;\n34(\n1):\n160\u2013\n173.\n2638820410.1002\/stem.2206"},{"issue":"1","key":"b21","series-title":"J Infect Dis","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/infdis\/145.1.94","article-title":"Diphtheria toxin and related proteins: effect of route of injection on toxicity and the determination of cytotoxicity for various cultured cells","volume":"145","author":"Pappenheimer \nAM \nJr","year":"1982","unstructured":"Pappenheimer \nAM \nJr\n, \n\nHarper \nAA\n, \n\nMoynihan \nM\n, \n\nBrockes \nJP\n\n. \nDiphtheria toxin and related proteins: effect of route of injection on toxicity and the determination of cytotoxicity for various cultured cells. \nJ Infect Dis. \n1982;\n145(\n1):\n94\u2013\n102.\n679813310.1093\/infdis\/145.1.94"},{"issue":"1","key":"b22","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/neu.1995.12.1","article-title":"A sensitive and reliable locomotor rating scale for open field testing in rats","volume":"12","author":"Basso \nDM","year":"1995","unstructured":"Basso \nDM\n, \n\nBeattie \nMS\n, \n\nBresnahan \nJC\n\n. \nA sensitive and reliable locomotor rating scale for open field testing in rats. \nJ Neurotrauma. \n1995;\n12(\n1):\n1\u2013\n21.\n778323010.1089\/neu.1995.12.1"},{"issue":"39","key":"b23","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"14069","DOI":"10.1073\/pnas.0507063102","article-title":"Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice","volume":"102","author":"Cummings \nBJ","year":"2005","unstructured":"Cummings \nBJ\n, \n\nUchida \nN\n, \n\nTamaki \nSJ\n, \n\n \nHuman neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. \nProc Natl Acad Sci U S A. \n2005;\n102(\n39):\n14069\u2013\n14074.\n1617237410.1073\/pnas.0507063102"},{"key":"b24","series-title":"Adv Exp Med Biol","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-4-431-56847-6_3","article-title":"Muse cells are endogenous reparative stem cells","volume":"1103","author":"Kushida \nY","year":"2018","unstructured":"Kushida \nY\n, \n\nWakao \nS\n, \n\nDezawa \nM\n\n. \nMuse cells are endogenous reparative stem cells. \nAdv Exp Med Biol. \n2018;\n1103:\n43\u2013\n68.\n10.1007\/978-4-431-56847-6_330484223"},{"issue":"2","key":"b25","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1161\/STROKEAHA.116.014950","article-title":"Human muse cells reconstruct neuronal circuitry in subacute lacunar stroke model","volume":"48","author":"Uchida \nH","year":"2017","unstructured":"Uchida \nH\n, \n\nNiizuma \nK\n, \n\nKushida \nY\n, \n\n \nHuman muse cells reconstruct neuronal circuitry in subacute lacunar stroke model. \nStroke. \n2017;\n48(\n2):\n428\u2013\n435.\n10.1161\/STROKEAHA.116.01495027999136"},{"issue":"5","key":"b26","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1089\/neu.2006.3771","article-title":"Transplantation of adult rat spinal cord stem\/progenitor cells for spinal cord injury","volume":"24","author":"Parr \nAM","year":"2007","unstructured":"Parr \nAM\n, \n\nKulbatski \nI\n, \n\nTator \nCH\n\n. \nTransplantation of adult rat spinal cord stem\/progenitor cells for spinal cord injury. \nJ Neurotrauma. \n2007;\n24(\n5):\n835\u2013\n845.\n10.1089\/neu.2006.377117518538"},{"issue":"3","key":"b27","series-title":"Nat Neurosci","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nn1405","article-title":"Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome","volume":"8","author":"Hofstetter \nCP","year":"2005","unstructured":"Hofstetter \nCP\n, \n\nHolmstr\u00f6m \nNA\n, \n\nLilja \nJA\n, \n\n \nAllodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. \nNat Neurosci. \n2005;\n8(\n3):\n346\u2013\n353.\n1571154210.1038\/nn1405"},{"issue":"9","key":"b28","series-title":"J Clin Invest","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1172\/JCI42957","article-title":"Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury","volume":"120","author":"Abematsu \nM","year":"2010","unstructured":"Abematsu \nM\n, \n\nTsujimura \nK\n, \n\nYamano \nM\n, \n\n \nNeurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. \nJ Clin Invest. \n2010;\n120(\n9):\n3255\u2013\n3266.\n10.1172\/JCI42957"},{"issue":"9","key":"b29","series-title":"Cell Transplant","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3727\/096368912X658791","article-title":"Transplantation of bone marrow stromal cell-derived neural precursor cells ameliorates deficits in a rat model of complete spinal cord transection","volume":"22","author":"Aizawa-Kohama \nM","year":"2013","unstructured":"Aizawa-Kohama \nM\n, \n\nEndo \nT\n, \n\nKitada \nM\n, \n\n \nTransplantation of bone marrow stromal cell-derived neural precursor cells ameliorates deficits in a rat model of complete spinal cord transection. \nCell Transplant. \n2013;\n22(\n9):\n1613\u2013\n1625.\n10.3727\/096368912X658791"},{"issue":"5","key":"b30","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1227\/01.NEU.0000341905.57162.1D","article-title":"Transplanted bone marrow stromal cells promote axonal regeneration and improve motor function in a rat spinal cord injury model","volume":"64","author":"Chiba \nY","year":"2009","unstructured":"Chiba \nY\n, \n\nKuroda \nS\n, \n\nMaruichi \nK\n, \n\n \nTransplanted bone marrow stromal cells promote axonal regeneration and improve motor function in a rat spinal cord injury model. \nNeurosurgery. \n2009;\n64(\n5):\n991\u2013\n1000.\n10.1227\/01.NEU.0000341905.57162.1D"},{"issue":"7","key":"b31","series-title":"Bone Marrow Transplant","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/sj.bmt.1705757","article-title":"Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury","volume":"40","author":"Parr \nAM","year":"2007","unstructured":"Parr \nAM\n, \n\nTator \nCH\n, \n\nKeating \nA\n\n. \nBone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. \nBone Marrow Transplant. \n2007;\n40(\n7):\n609\u2013\n619.\n1760351410.1038\/sj.bmt.1705757"},{"issue":"3","key":"b32","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0006-8993(74)90922-6","article-title":"Functional regeneration of 5-hydroxytryptamine nerve terminals in the rat spinal cord following 5,6-dihydroxytryptamine induced degeneration","volume":"78","author":"Nygren \nLG","year":"1974","unstructured":"Nygren \nLG\n, \n\nFuxe \nK\n, \n\nJonsson \nG\n, \n\nOlson \nL\n\n. \nFunctional regeneration of 5-hydroxytryptamine nerve terminals in the rat spinal cord following 5,6-dihydroxytryptamine induced degeneration. \nBrain Res. \n1974;\n78(\n3):\n377\u2013\n394.\n442471110.1016\/0006-8993(74)90922-6"},{"issue":"4","key":"b33","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1073\/pnas.042678299","article-title":"Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery","volume":"99","author":"Hofstetter \nCP","year":"2002","unstructured":"Hofstetter \nCP\n, \n\nSchwarz \nEJ\n, \n\nHess \nD\n, \n\n \nMarrow stromal cells form guiding strands in the injured spinal cord and promote recovery. \nProc Natl Acad Sci U S A. \n2002;\n99(\n4):\n2199\u2013\n2204.\n1185451610.1073\/pnas.042678299"},{"key":"b34","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.brainres.2010.05.011","article-title":"Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome","volume":"1343","author":"Osaka \nM","year":"2010","unstructured":"Osaka \nM\n, \n\nHonmou \nO\n, \n\nMurakami \nT\n, \n\n \nIntravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. \nBrain Res. \n2010;\n1343:\n226\u2013\n235.\n2047075910.1016\/j.brainres.2010.05.011"},{"key":"b35","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.expneurol.2013.06.024","article-title":"Combinatory treatments needed for spinal cord injury","volume":"248","author":"Olson \nL","year":"2013","unstructured":"Olson \nL\n\n. \nCombinatory treatments needed for spinal cord injury. \nExp Neurol. \n2013;\n248:\n309\u2013\n315.\n10.1016\/j.expneurol.2013.06.02423830948"},{"key":"b36","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.expneurol.2015.03.001","article-title":"Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells","volume":"267","author":"Matsushita \nT","year":"2015","unstructured":"Matsushita \nT\n, \n\nLankford \nKL\n, \n\nArroyo \nEJ\n, \n\n \nDiffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells. \nExp Neurol. \n2015;\n267:\n152\u2013\n164.\n2577180110.1016\/j.expneurol.2015.03.001"},{"key":"b37","series-title":"Nat Commun","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/ncomms2248","article-title":"Luminescent proteins for high-speed single-cell and whole-body imaging","volume":"3","author":"Saito \nK","year":"2012","unstructured":"Saito \nK\n, \n\nChang \nYF\n, \n\nHorikawa \nK\n, \n\n \nLuminescent proteins for high-speed single-cell and whole-body imaging. \nNat Commun. \n2012;\n3:\n1262.\n10.1038\/ncomms224823232392"}],"container-title":["Journal of Neurosurgery: Spine"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/34\/4\/article-p648.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/34\/4\/article-p648.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/34\/4\/article-p648.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T01:01:00Z","timestamp":1751072460000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/34\/4\/article-p648.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":37,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2020.7.spine20293","relation":{},"ISSN":["1547-5654"],"issn-type":[{"value":"1547-5654","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}